ID

30607

Beschreibung

Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00930475

Link

https://clinicaltrials.gov/show/NCT00930475

Stichworte

Versionen (1)
  1. 17.06.18 17.06.18 -
Rechteinhaber

see clinicaltrials.gov

Hochgeladen am

17. Juni 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT00930475

Englisch

Eligibility Breast Cancer NCT00930475

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult female patients
Beschreibung

Gender; Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
at least two prior chemotherapies due to metastatic or inoperable breast cancer
Beschreibung

Prior Chemotherapy Due to Carcinoma breast stage IV; Prior Chemotherapy Due to Breast Carcinoma, Inoperable

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0278488
UMLS CUI [2,1]
C1514457
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0678222
UMLS CUI [2,4]
C0205187
karnofsky performance status of at least 60%
Beschreibung

Karnofsky Performance Status

Datentyp

boolean

Alias
UMLS CUI [1]
C0206065
pretreatment with at least one taxane and one anthracycline
Beschreibung

Pretreatment taxane; Pretreatment Anthracyclines

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3539076
UMLS CUI [1,2]
C0215136
UMLS CUI [2,1]
C3539076
UMLS CUI [2,2]
C0282564
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous treatment with mtor-inhibitors, carboplatin, cisplatin or oxaliplatin
Beschreibung

mTOR Inhibitor, Therapeutic procedure, Previous; Carboplatin, Therapeutic procedure, Previous; Cisplatin, Therapeutic procedure, Previous; oxaliplatin, Therapeutic procedure, Previous

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2746052
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0205156
UMLS CUI [2,1]
C0079083
UMLS CUI [2,2]
C0087111
UMLS CUI [2,3]
C0205156
UMLS CUI [3,1]
C0008838
UMLS CUI [3,2]
C0087111
UMLS CUI [3,3]
C0205156
UMLS CUI [4,1]
C0069717
UMLS CUI [4,2]
C0087111
UMLS CUI [4,3]
C0205156
inadequate organ function including bone marrow function
Beschreibung

body system or organ function, Inadequate

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0678852
UMLS CUI [1,2]
C0205412
bleeding tumours
Beschreibung

Malignant Neoplasms, Hemorrhage

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0019080
known uncontrolled metastases in cns or carcinomatous meningosis
Beschreibung

CNS metastases, Uncontrolled; Meningeal Carcinomatosis

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0686377
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C0220654
patients who have been treated during the last five days with inhibitors or inducers of cyp3a
Beschreibung

Cytochrome P450 3A4 Inhibitor, Therapeutic procedure, Previous; Cytochrome P450 3A4 Inducer, Therapeutic procedure, Previous

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3830624
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0205156
UMLS CUI [2,1]
C3830625
UMLS CUI [2,2]
C0087111
UMLS CUI [2,3]
C0205156
serious pulmonary, neurological, endocrinological or other disorders interfering with this study medication, especially patients with known lung fibrosis, emphysema or severe copd
Beschreibung

Bronchopulmonary disease, Serious, Interferes with clinical trial drug; nervous system disorder, Serious, Interferes with, clinical trial drug; Endocrine System Diseases, Serious, Interferes with clinical trial drug; Disease, Other, Interferes with clinical trial drug

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1096000
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0521102
UMLS CUI [1,4]
C3854006
UMLS CUI [2,1]
C0027765
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C0521102
UMLS CUI [2,4]
C3854006
UMLS CUI [3,1]
C0014130
UMLS CUI [3,2]
C0205404
UMLS CUI [3,3]
C0521102
UMLS CUI [3,4]
C3854006
UMLS CUI [4,1]
C0012634
UMLS CUI [4,2]
C0205394
UMLS CUI [4,3]
C0521102
UMLS CUI [4,4]
C3854006
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Breast Cancer NCT00930475

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Gender; Age
Item
adult female patients
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Prior Chemotherapy Due to Carcinoma breast stage IV; Prior Chemotherapy Due to Breast Carcinoma, Inoperable
Item
at least two prior chemotherapies due to metastatic or inoperable breast cancer
boolean
C1514457 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0278488 (UMLS CUI [1,3])
C1514457 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0678222 (UMLS CUI [2,3])
C0205187 (UMLS CUI [2,4])
Karnofsky Performance Status
Item
karnofsky performance status of at least 60%
boolean
C0206065 (UMLS CUI [1])
Pretreatment taxane; Pretreatment Anthracyclines
Item
pretreatment with at least one taxane and one anthracycline
boolean
C3539076 (UMLS CUI [1,1])
C0215136 (UMLS CUI [1,2])
C3539076 (UMLS CUI [2,1])
C0282564 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
mTOR Inhibitor, Therapeutic procedure, Previous; Carboplatin, Therapeutic procedure, Previous; Cisplatin, Therapeutic procedure, Previous; oxaliplatin, Therapeutic procedure, Previous
Item
previous treatment with mtor-inhibitors, carboplatin, cisplatin or oxaliplatin
boolean
C2746052 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
C0079083 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0205156 (UMLS CUI [2,3])
C0008838 (UMLS CUI [3,1])
C0087111 (UMLS CUI [3,2])
C0205156 (UMLS CUI [3,3])
C0069717 (UMLS CUI [4,1])
C0087111 (UMLS CUI [4,2])
C0205156 (UMLS CUI [4,3])
body system or organ function, Inadequate
Item
inadequate organ function including bone marrow function
boolean
C0678852 (UMLS CUI [1,1])
C0205412 (UMLS CUI [1,2])
Malignant Neoplasms, Hemorrhage
Item
bleeding tumours
boolean
C0006826 (UMLS CUI [1,1])
C0019080 (UMLS CUI [1,2])
CNS metastases, Uncontrolled; Meningeal Carcinomatosis
Item
known uncontrolled metastases in cns or carcinomatous meningosis
boolean
C0686377 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0220654 (UMLS CUI [2])
Cytochrome P450 3A4 Inhibitor, Therapeutic procedure, Previous; Cytochrome P450 3A4 Inducer, Therapeutic procedure, Previous
Item
patients who have been treated during the last five days with inhibitors or inducers of cyp3a
boolean
C3830624 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
C3830625 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0205156 (UMLS CUI [2,3])
Bronchopulmonary disease, Serious, Interferes with clinical trial drug; nervous system disorder, Serious, Interferes with, clinical trial drug; Endocrine System Diseases, Serious, Interferes with clinical trial drug; Disease, Other, Interferes with clinical trial drug
Item
serious pulmonary, neurological, endocrinological or other disorders interfering with this study medication, especially patients with known lung fibrosis, emphysema or severe copd
boolean
C1096000 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C3854006 (UMLS CUI [1,4])
C0027765 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0521102 (UMLS CUI [2,3])
C3854006 (UMLS CUI [2,4])
C0014130 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
C0521102 (UMLS CUI [3,3])
C3854006 (UMLS CUI [3,4])
C0012634 (UMLS CUI [4,1])
C0205394 (UMLS CUI [4,2])
C0521102 (UMLS CUI [4,3])
C3854006 (UMLS CUI [4,4])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video